Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074646
Status:
COMPLETED
Last Update Posted:
2007-01-04
First Post:
2003-12-17
Brief Title:
Phase I Trial of CC-8490 for the Treatment of Subjects With RecurrentRefractory High-Grade Gliomas
Sponsor:
Celgene Corporation
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
CC-8490-GLIO-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None